{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:25:41Z","timestamp":1793291141295,"version":"4.5.0"},"reference-count":188,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Aldosterone is a key regulator of sodium reabsorption, potassium secretion, and acid\u2013base balance along the aldosterone-sensitive distal nephron (ASDN), where it exerts coordinated, segment-specific control over tubular transport. Although essential for volume conservation in terrestrial environments, aldosterone signaling has become maladaptive in modern sodium-rich contexts, contributing to systemic inflammation, fibrosis, and progression of cardiovascular and kidney disease. This review examines the regulation of aldosterone biosynthesis, the molecular diversity of mineralocorticoid receptor (MR) signaling, and the cellular mechanisms by which aldosterone shapes ion transport in the ASDN. A detailed classification of aldosterone-related disorders is presented, including hyperaldosteronism, pseudo-hyperaldosteronism, aldosterone resistance, and hypoaldosteronism. The therapeutic section focuses on MR overactivation in chronic kidney disease, critically appraising the clinical use of steroidal and non-steroidal MR antagonists. In addition, emerging strategies targeting aldosterone synthesis and downstream inflammatory pathways are discussed as potential approaches to address residual cardiorenal risk and the aldosterone breakthrough phenomenon. Together, these insights support a mechanistic reappraisal of aldosterone as both a physiological modulator and a pathologic driver, with implications for biomarker-guided, targeted therapy.<\/jats:p>","DOI":"10.3390\/ijms26188829","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T14:14:55Z","timestamp":1757513695000},"page":"8829","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Aldosterone: From Essential Tubular Regulator to Pathological Driver\u2014Physiology, Disease, and Therapeutic Advances"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8527-5594","authenticated-orcid":false,"given":"Camillo Tancredi","family":"Strizzi","sequence":"first","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"},{"name":"Nephrology, Dialysis and Transplantation Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"},{"name":"Nephrology, Dialysis and Transplantation Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"},{"name":"Nephrology, Dialysis and Transplantation Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-4226","authenticated-orcid":false,"given":"Francesco","family":"Pesce","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"},{"name":"Division of Renal Medicine, Ospedale Isola Tiberina\u2014Gemelli Isola, 00186 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"ref_1","unstructured":"Smith, H.W. (1953). From Fish to Philosopher, Little, Brown and Company. [1st ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2003.10.004","article-title":"The Discovery, Isolation and Identification of Aldosterone: Reflections on Emerging Regulation and Function","volume":"217","author":"Tait","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1152\/physrev.00011.2014","article-title":"Epithelial Sodium Transport and Its Control by Aldosterone: The Story of Our Internal Environment Revisited","volume":"95","author":"Rossier","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000368266","article-title":"Effect of Mineralocorticoids on Acid-Base Balance","volume":"128","author":"Wagner","year":"2014","journal-title":"Nephron Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF03344112","article-title":"Aldosterone and the Conquest of Land","volume":"29","author":"Colombo","year":"2006","journal-title":"J. Endocrinol. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-16-0661","article-title":"30 Years of the Mineralocorticoid Receptor: Evolution of the Mineralocorticoid Receptor: Sequence, Structure and Function","volume":"234","author":"Baker","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of Aldosterone to Cardiovascular and Renal Inflammation and Fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e030142","DOI":"10.1161\/JAHA.123.030142","article-title":"Adverse Effects of Aldosterone: Beyond Blood Pressure","volume":"13","author":"Brown","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2011.11.026","article-title":"Aldosterone and Mineralocorticoid Receptors: A Personal Reflection","volume":"350","author":"Funder","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/mend-5-10-1513","article-title":"The Product of the CYP11B2 Gene Is Required for Aldosterone Biosynthesis in the Human Adrenal Cortex","volume":"5","author":"Curnow","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bollag, W.B. (2014). Regulation of Aldosterone Synthesis and Secretion. Comprehensive Physiology, Wiley.","DOI":"10.1002\/cphy.c130037"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.2009070759","article-title":"Macula Densa Sensing and Signaling Mechanisms of Renin Release","volume":"21","author":"Harris","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Reninangiotensin System Revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1677\/JME-08-0112","article-title":"Role of Angiotensin II-Induced Rapid Response Genes in the Regulation of Enzymes Needed for Aldosterone Synthesis","volume":"42","author":"Nogueira","year":"2009","journal-title":"J. Mol. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Volonte, D., Sedorovitz, M., Cespedes, V.E., Beecher, M.L., and Galbiati, F. (2021). Cell Autonomous Angiotensin II Signaling Controls the Pleiotropic Functions of Oncogenic K-Ras. J. Biol. Chem., 296.","DOI":"10.1074\/jbc.RA120.015188"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.2000.00970.x","article-title":"Aldosterone and Potassium Secretion by the Cortical Collecting Duct","volume":"57","author":"Palmer","year":"2000","journal-title":"Kidney Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1172\/JCI61996","article-title":"Zona Glomerulosa Cells of the Mouse Adrenal Cortex Are Intrinsic Electrical Oscillators","volume":"122","author":"Hu","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"El Ghorayeb, N., Bourdeau, I., and Lacroix, A. (2016). Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism. Front. Endocrinol., 7.","DOI":"10.3389\/fendo.2016.00072"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways","volume":"84","author":"Hunyady","year":"2004","journal-title":"Physiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0022-4731(84)90225-5","article-title":"Circadian Rhythm of Plasma Aldosterone and Time Dependent Alterations of Aldosterone Regulators","volume":"20","author":"Ryoyu","year":"1984","journal-title":"J. Steroid Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00251044","article-title":"Short- and Long-Term Effects of ACTH on the Adrenal Zona Glomerulosa of the Rat","volume":"243","author":"Mazzocchi","year":"1986","journal-title":"Cell Tissue Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EC-14-0086","article-title":"Role of Endogenous ACTH on Circadian Aldosterone Rhythm in Patients with Primary Aldosteronism","volume":"3","author":"Sonoyama","year":"2014","journal-title":"Endocr. Connect."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lim, J.S., Plaska, S.W., Rege, J., Rainey, W.E., and Turcu, A.F. (2021). Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.644382"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM198511213132106","article-title":"Atrial Natriuretic Hormone, the Renin\u2013Aldosterone Axis, and Blood Pressure\u2013Electrolyte Homeostasis","volume":"313","author":"Flier","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_25","first-page":"24S","article-title":"Interaction between Atrial Natriuretic Peptide and the Renin Angiotensin Aldosterone System","volume":"87","author":"Johnston","year":"1989","journal-title":"Am. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/JOE-16-0452","article-title":"Regulation of Aldosterone Secretion by Mineralocorticoid Receptor\u2013Mediated Signaling","volume":"232","author":"Chong","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Pang, Y., Gong, S., Tetti, M., Sun, Z., Mir-Bashiri, S., Bidlingmaier, M., Kn\u00f6sel, T., Wolf, E., Reincke, M., and Kemter, E. (2025). EGR1 Regulates Oxidative Stress and Aldosterone Production in Adrenal Cells and Aldosterone-Producing Adenomas. Redox Biol., 80.","DOI":"10.1016\/j.redox.2025.103498"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Takeda, Y., Demura, M., Kometani, M., Karashima, S., Yoneda, T., and Takeda, Y. (2023). Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065782"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e008281","DOI":"10.1161\/JAHA.117.008281","article-title":"Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II","volume":"7","author":"Takeda","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/HJH.0000000000002742","article-title":"Effect of Potassium on DNA Methylation of Aldosterone Synthase Gene","volume":"39","author":"Takeda","year":"2021","journal-title":"J. Hypertens."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","article-title":"Mineralocorticoid Receptors: Distribution and Activation","volume":"10","author":"Funder","year":"2005","journal-title":"Heart Fail. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1046\/j.1523-1755.2000.00976.x","article-title":"Mineralocorticoid Selectivity: Molecular and Cellular Aspects","volume":"57","author":"Farman","year":"2000","journal-title":"Kidney Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ki.2011.48","article-title":"Mineralocorticoid Receptor Activation and Blockade: An Emerging Paradigm in Chronic Kidney Disease","volume":"79","author":"Bertocchio","year":"2011","journal-title":"Kidney Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of Mineralocorticoid Receptors from Macrophages Protects against Deoxycorticosterone\/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-Aldosterone Treatment and the Prevention of Myocardial Fibrosis in Primary and Secondary Hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","article-title":"Cardiac Specific Increase in Aldosterone Production Induces Coronary Dysfunction in Aldosterone Synthase\u2013Transgenic Mice","volume":"110","author":"Garnier","year":"2004","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac Fibrosis","volume":"117","author":"Frangogiannis","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/ATVBAHA.119.312954","article-title":"Endothelial Mineralocorticoid Receptors Contribute to Vascular Inflammation in Atherosclerosis in a Sex-Specific Manner","volume":"39","author":"Moss","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00395-024-01032-6","article-title":"Mineralocorticoid Receptor Promotes Cardiac Macrophage Inflammaging","volume":"119","author":"Fraccarollo","year":"2024","journal-title":"Basic Res. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/pr.115.011106","article-title":"Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology","volume":"68","author":"Jaisser","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/MCB.01190-09","article-title":"The Hsp90-FKBP52 Complex Links the Mineralocorticoid Receptor to Motor Proteins and Persists Bound to the Receptor in Early Nuclear Events","volume":"30","author":"Galigniana","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tem.2011.08.001","article-title":"FKBP51 and FKBP52 in Signaling and Disease","volume":"22","author":"Storer","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"F377","DOI":"10.1152\/ajprenal.00143.2002","article-title":"Concerted Action of ENaC, Nedd4-2, and Sgk1 in Transepithelial Na(+) Transport","volume":"283","author":"Kamynina","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/CS20171525","article-title":"Aldosterone, SGK1, and Ion Channels in the Kidney","volume":"132","author":"Valinsky","year":"2018","journal-title":"Clin. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1210\/me.2005-0193","article-title":"Serum- and Glucocorticoid-Regulated Kinase 1 Regulates Ubiquitin Ligase Neural Precursor Cell-Expressed, Developmentally Down-Regulated Protein 4-2 by Inducing Interaction with 14-3-3","volume":"19","author":"Bhalla","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1172\/JCI7840","article-title":"Aldosterone-Mediated Regulation of ENaC Alpha, Beta, and Gamma Subunit Proteins in Rat Kidney","volume":"104","author":"Masilamani","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1210\/mend-3-9-1369","article-title":"Aldosterone Induces a Rapid Increase in the Rate of Na,K-ATPase Gene Transcription in Cultured Kidney Cells","volume":"3","author":"Verrey","year":"1989","journal-title":"Mol. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1046\/j.1523-1755.2000.00961.x","article-title":"Regulation of the Epithelial Na+ Channel by Aldosterone: Open Questions and Emerging Answers","volume":"57","author":"Garty","year":"2000","journal-title":"Kidney Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"47087","DOI":"10.1074\/jbc.M107165200","article-title":"Short Term Effect of Aldosterone on Na,K-ATPase Cell Surface Expression in Kidney Collecting Duct Cells","volume":"276","author":"Summa","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"155831","DOI":"10.1016\/j.metabol.2024.155831","article-title":"Endothelial Cell Serum and Glucocorticoid Regulated Kinase 1 (SGK1) Mediates Vascular Stiffening","volume":"154","author":"Zhang","year":"2024","journal-title":"Metabolism"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1469-7793.1998.255bi.x","article-title":"Non-Genomic Action of the Mineralocorticoid Aldosterone on Cytosolic Sodium in Cultured Kidney Cells","volume":"511","author":"Gekle","year":"1998","journal-title":"J. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2005-0004","article-title":"The Nongenomic Actions of Aldosterone","volume":"26","author":"Funder","year":"2005","journal-title":"Endocr. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1046\/j.1523-1755.2000.00980.x","article-title":"Specific Nongenomic Actions of Aldosterone","volume":"57","author":"Falkenstein","year":"2000","journal-title":"Kidney Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1523-1755.2000.00981.x","article-title":"Nongenomic Effects of Aldosterone on Ca2+ in M-1 Cortical Collecting Duct Cells","volume":"57","author":"Harvey","year":"2000","journal-title":"Kidney Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2009.02.005","article-title":"New Aspects of Rapid Aldosterone Signaling","volume":"308","author":"Grossmann","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.steroids.2013.10.016","article-title":"Rapid Mineralocorticoid Receptor Trafficking","volume":"81","author":"Gekle","year":"2014","journal-title":"Steroids"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tem.2004.08.002","article-title":"Non-Genomic Effects of Aldosterone: New Actions and Questions","volume":"15","author":"Chun","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, X., Kuang, W., Qiu, Z., and Zhou, Z. (2023). G Protein\u2013Coupled Estrogen Receptor: A Promising Therapeutic Target for Aldosterone-Induced Hypertension. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1226458"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1210\/ME.2014-1410","article-title":"Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury","volume":"29","author":"Ashton","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1161\/CIRCULATIONAHA.111.067918","article-title":"Aldosterone, Mineralocorticoid Receptor Activation, and Cardiovascular Remodeling","volume":"124","author":"Leopold","year":"2011","journal-title":"Circulation"},{"key":"ref_63","first-page":"689360","article-title":"The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int. J. Inflamm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","article-title":"Aldosterone, Inflammation, Immune System, and Hypertension","volume":"34","author":"Ferreira","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"F556","DOI":"10.1152\/ajprenal.00332.2016","article-title":"NLRP3 Inflammasome Activation Contributes to Aldosterone-Induced Podocyte Injury","volume":"312","author":"Bai","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"108053","DOI":"10.1016\/j.pharmthera.2021.108053","article-title":"Targeting the NLRP3 Inflammasome in Cardiovascular Diseases","volume":"236","author":"Toldo","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1681\/ASN.2008020232","article-title":"Aldosterone Activates NF-\u03baB in the Collecting Duct","volume":"20","author":"Leroy","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/JOE-20-0161","article-title":"Novel Mineralocorticoid Receptor Mechanisms Regulate Cardiac Tissue Inflammation in Male Mice","volume":"246","author":"Ong","year":"2020","journal-title":"J. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/ATVBAHA.115.307031","article-title":"Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1\/NF-\u03baB Pathways","volume":"36","author":"Sun","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone Promotes Autoimmune Damage by Enhancing Th17-Mediated Immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"14037","DOI":"10.1038\/ncomms14037","article-title":"CD8+ T Cells Stimulate Na-Cl Co-Transporter NCC in Distal Convoluted Tubules Leading to Salt-Sensitive Hypertension","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Nakamura, T., Bonnard, B., Palacios-Ramirez, R., Fern\u00e1ndez-Celis, A., Jaisser, F., and L\u00f3pez-Andr\u00e9s, N. (2022). Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone\/Salt-Induced Glomerular Injury. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126680"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biocel.2014.07.020","article-title":"Soluble Biglycan as a Biomarker of Inflammatory Renal Diseases","volume":"54","author":"Hsieh","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e2413737121","DOI":"10.1073\/pnas.2413737121","article-title":"The Glucocorticoid Receptor Potentiates Aldosterone-Induced Transcription by the Mineralocorticoid Receptor","volume":"121","author":"Johnson","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"T23","DOI":"10.1530\/JOE-17-0060","article-title":"30 Years of the Mineralocorticoid Receptor: Coregulators as Mediators of Mineralocorticoid Receptor Signalling Diversity","volume":"234","author":"Fuller","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.1096\/fj.201902254RR","article-title":"Aldosterone-induced microRNAs Act as Feedback Regulators of Mineralocorticoid Receptor Signaling in Kidney Epithelia","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Hagiwara, S., Gohda, T., Kantharidis, P., Okabe, J., Murakoshi, M., and Suzuki, Y. (2024). Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020869"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"R498","DOI":"10.1152\/ajpregu.00182.2014","article-title":"Estrogen Status and the Renin Angiotensin Aldosterone System","volume":"307","author":"Floras","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000092984","article-title":"Salt Sensitivity and Hypertension after Menopause: Role of Nitric Oxide and Angiotensin II","volume":"26","author":"Raij","year":"2006","journal-title":"Am. J. Nephrol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ejhf.1740","article-title":"Sex Differences in Mineralocorticoid Receptor Antagonist Trials: A Pooled Analysis of Three Large Clinical Trials","volume":"22","author":"Rossello","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40620-019-00684-1","article-title":"Recent Insights into Sodium and Potassium Handling by the Aldosterone-Sensitive Distal Nephron: A Review of the Relevant Physiology","volume":"33","author":"Rossi","year":"2020","journal-title":"J. Nephrol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ackd.2017.08.001","article-title":"Sodium Homeostasis in Chronic Kidney Disease","volume":"24","author":"Soi","year":"2017","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MNH.0b013e32835b6551","article-title":"Effects of Angiotensin II on Kinase-Mediated Sodium and Potassium Transport in the Distal Nephron","volume":"22","author":"Zietse","year":"2013","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ki.2010.290","article-title":"Angiotensin II Induces Phosphorylation of the Thiazide-Sensitive Sodium Chloride Cotransporter Independent of Aldosterone","volume":"79","author":"Lim","year":"2011","journal-title":"Kidney Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"F1119","DOI":"10.1152\/ajprenal.00543.2014","article-title":"Aldosterone Modulates Thiazide-Sensitive Sodium Chloride Cotransporter Abundance via DUSP6-Mediated ERK1\/2 Signaling Pathway","volume":"308","author":"Feng","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00424-012-1104-0","article-title":"Aldosterone Does Not Require Angiotensin II to Activate NCC through a WNK4-SPAK-Dependent Pathway","volume":"463","author":"Lim","year":"2012","journal-title":"Pflugers Arch."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Kortenoeven, M.L.A., Esteva-Font, C., Dimke, H., Poulsen, S.B., Murali, S.K., and Fenton, R.A. (2021). High Dietary Potassium Causes Ubiquitin-Dependent Degradation of the Kidney Sodium-Chloride Cotransporter. J. Biol. Chem., 297.","DOI":"10.1016\/j.jbc.2021.100915"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1440-1681.2007.04844.x","article-title":"Regulation of Epithelial Na+ Channels by Aldosterone: Role of Sgk1","volume":"35","author":"Lee","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1073\/pnas.0307321101","article-title":"Nongenomic Stimulation of Vacuolar H-ATPases in Intercalated Renal Tubule Cells by Aldosterone","volume":"101","author":"Winter","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1242\/jeb.028803","article-title":"Regulation of the V-ATPase in Kidney Epithelial Cells: Dual Role in Acid\u2013Base Homeostasis and Vesicle Trafficking","volume":"212","author":"Brown","year":"2009","journal-title":"J. Exp. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"C1251","DOI":"10.1152\/ajpcell.00076.2011","article-title":"Aldosterone Stimulates Vacuolar H+-ATPase Activity in Renal Acid-Secretory Intercalated Cells Mainly via a Protein Kinase C-Dependent Pathway","volume":"301","author":"Winter","year":"2011","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lab.2005.08.013","article-title":"H+-ATPase Activity in Selective Disruption of H+-K+-ATPase Alpha 1 Gene of Mice under Normal and K-Depleted Conditions","volume":"147","author":"Nakamura","year":"2006","journal-title":"J. Lab. Clin. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.ajkd.2019.03.427","article-title":"Physiology and Pathophysiology of Potassium Homeostasis: Core Curriculum 2019","volume":"74","author":"Palmer","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ajh\/hpz054","article-title":"Role of Pendrin in the Pathophysiology of Aldosterone-Induced Hypertension","volume":"32","author":"Shibata","year":"2019","journal-title":"Am. J. Hypertens."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MNH.0000000000000669","article-title":"Regulation of Renal Pendrin Activity by Aldosterone","volume":"30","author":"Bourgeois","year":"2021","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"F593","DOI":"10.1152\/ajprenal.00454.2003","article-title":"Sodium and Potassium Handling by the Aldosterone-Sensitive Distal Nephron: The Pivotal Role of the Distal and Connecting Tubule","volume":"287","author":"Meneton","year":"2004","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physiol.00049.2010","article-title":"Aldosterone Paradox: Differential Regulation of Ion Transport in Distal Nephron","volume":"26","author":"Arroyo","year":"2011","journal-title":"Physiology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and Treatment of Primary Aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"101399","DOI":"10.1016\/j.beem.2020.101399","article-title":"The Spectrum of Low-Renin Hypertension","volume":"34","author":"Buffolo","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a Mediator of Cardiovascular Damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0889-8529(18)30029-X","article-title":"Secondary Aldosteronism","volume":"24","author":"Corry","year":"1995","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ncpendmet0430","article-title":"Primary Aldosteronism: Current Knowledge and Controversies in Conn\u2019s Syndrome","volume":"3","author":"Schirpenbach","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"101386","DOI":"10.1016\/j.beem.2020.101386","article-title":"Adrenocortical Hyperplasia: A Multifaceted Disease","volume":"34","author":"Bourdeau","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1055\/s-0035-1564166","article-title":"An Update on Familial Hyperaldosteronism","volume":"47","author":"Korah","year":"2015","journal-title":"Horm. Metab. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvae041","article-title":"Familial Hyperaldosteronism: An European Reference Network on Rare Endocrine Conditions Clinical Practice Guideline","volume":"190","author":"Mulatero","year":"2024","journal-title":"Eur. J. Endocrinol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajh.2010.174","article-title":"Renovascular Hypertension and Ischemic Nephropathy","volume":"23","author":"Textor","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1210\/clinem\/dgad516","article-title":"Approach to the Patient: Reninoma","volume":"109","author":"Hayes","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11897-004-0005-8","article-title":"Aldosterone in Heart Failure: Pathophysiology and Treatment","volume":"1","author":"Struthers","year":"2004","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/MNH.0000000000000578","article-title":"Mechanisms of Sodium Retention in Nephrotic Syndrome","volume":"29","author":"Hinrichs","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","article-title":"Gitelman Syndrome: Consensus and Guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"91","author":"Blanchard","year":"2017","journal-title":"Kidney Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1681\/ASN.2017060600","article-title":"Salt-Losing Tubulopathies in Children: What\u2019s New, What\u2019s Controversial?","volume":"29","author":"Kleta","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2215\/CJN.14201021","article-title":"Syndromes of Pseudo-Hyperaldosteronism","volume":"17","author":"Rizzolo","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_115","first-page":"199","article-title":"A Familial Renal Disorder Simulating Primary Aldosteronism but with Negligible Aldosterone Secretion","volume":"76","author":"Liddle","year":"1966","journal-title":"Trans Assoc Physicians"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","article-title":"Liddle\u2019s Syndrome: Heritable Human Hypertension Caused by Mutations in the \u03b2 Subunit of the Epithelial Sodium Channel","volume":"79","author":"Shimkets","year":"1994","journal-title":"Cell"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12967-022-03698-9","article-title":"Apparent Mineralocorticoid Excess: Comprehensive Overview of Molecular Genetics","volume":"20","author":"Lu","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0960-0760(02)00033-X","article-title":"Glycyrrhizic Acid Suppresses Type 2 11\u03b2-Hydroxysteroid Dehydrogenase Expression in Vivo","volume":"80","author":"Tanahashi","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","article-title":"Association of Hypertension and Hypokalemia with Cushing\u2019s Syndrome Caused by Ectopic ACTH Secretion: A Series of 58 Cases","volume":"970","author":"Torpy","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_120","unstructured":"Rahman, M., and Anjum, F. (2025). Fludrocortisone. StatPearls, StatPearls Publishing."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/ndt\/gfae241","article-title":"Mineralocorticoid Receptor Antagonism for Non-Diabetic Kidney Disease","volume":"40","author":"Jaisser","year":"2025","journal-title":"Nephrol. Dial. Transplant"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00125-023-06031-1","article-title":"Mineralocorticoid Receptor Overactivation: Targeting Systemic Impact with Non-Steroidal Mineralocorticoid Receptor Antagonists","volume":"67","author":"Savarese","year":"2024","journal-title":"Diabetologia"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Tesch, G.H., and Young, M.J. (2017). Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00313"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41440-018-0158-6","article-title":"Pathophysiological Mechanisms of Mineralocorticoid Receptor-Dependent Cardiovascular and Chronic Kidney Disease","volume":"42","author":"Nishiyama","year":"2019","journal-title":"Hypertens. Res."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Miyasako, K., Maeoka, Y., and Masaki, T. (2024). Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010053"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10157-010-0298-8","article-title":"Activation of the Aldosterone\/Mineralocorticoid Receptor System in Chronic Kidney Disease and Metabolic Syndrome","volume":"14","author":"Nagase","year":"2010","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"An, D.-Y., Tan, J., Lu, Y.-D., Wen, Z.-H., Bao, Y.-N., Yao, Z.-H., Chen, Z.-Y., Wang, P.-P., Zhou, W., and Yang, Q. (2024). Focus on Podocytes: Diabetic Kidney Disease and Renal Fibrosis\u2014A Global Bibliometric Analysis (2000\u20132024). Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1454586"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.kisu.2021.11.006","article-title":"The Role of Mineralocorticoid Receptor Activation in Kidney Inflammation and Fibrosis","volume":"12","author":"Luther","year":"2022","journal-title":"Kidney Int. Suppl."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/ndt\/gfg339","article-title":"Aldosterone Receptor Blockade and the Role of Eplerenone: Evolving Perspectives","volume":"18","author":"Epstein","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The Incidence and Implications of Aldosterone Breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1097\/HJH.0000000000002187","article-title":"Effects of Mineralocorticoid Receptor Antagonists in Proteinuric Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"37","author":"Alexandrou","year":"2019","journal-title":"J. Hypertens."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Currie, G., Taylor, A.H.M., Fujita, T., Ohtsu, H., Lindhardt, M., Rossing, P., Boesby, L., Edwards, N.C., Ferro, C.J., and Townend, J.N. (2016). Effect of Mineralocorticoid Receptor Antagonists on Proteinuria and Progression of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. BMC Nephrol., 17.","DOI":"10.1186\/s12882-016-0337-0"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","article-title":"Long-Term Effects of Spironolactone on Proteinuria and Kidney Function in Patients with Chronic Kidney Disease","volume":"70","author":"Bianchi","year":"2006","journal-title":"Kidney Int."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ki.1996.111","article-title":"Risk of Developing End-Stage Renal Disease in a Cohort of Mass Screening","volume":"49","author":"Iseki","year":"1996","journal-title":"Kidney Int."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrneph.2012.42","article-title":"Proteinuria Should Be Used as a Surrogate in CKD","volume":"8","author":"Cravedi","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"sfaf038","DOI":"10.1093\/ckj\/sfaf038","article-title":"Does Low-Dose Spironolactone Increase Cardiovascular Protection in Patients with Chronic Kidney Disease?","volume":"18","author":"Sarafidis","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/JOE-21-0323","article-title":"Mineralocorticoid Receptor Antagonists, Heart Failure and Predictive Biomarkers","volume":"253","author":"Karthigan","year":"2022","journal-title":"J. Endocrinol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1745-6215-15-160","article-title":"Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) Trial\u2013a Multi-Centre, Prospective, Randomised, Open, Blinded End-Point, 36-Month Study of 2,616 Patients within Primary Care with Stage 3b Chronic Kidney Disease to Compare the Efficacy of Spironolactone 25 Mg Once Daily in Addition to Routine Care on Mortality and Cardiovascular Outcomes versus Routine Care Alone: Study Protocol for a Randomized Controlled Trial","volume":"15","author":"Hill","year":"2014","journal-title":"Trials"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000515622","article-title":"Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the Present","volume":"52","author":"Epstein","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2021070942","article-title":"Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial","volume":"33","author":"Agarwal","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ajh\/hpac124","article-title":"The Nonsteroidal Mineralocorticoid-Receptor-Antagonist Finerenone in Cardiorenal Medicine: A State-of-the-Art Review of the Literature","volume":"36","author":"Georgianos","year":"2023","journal-title":"Am. J. Hypertens."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2215\/CJN.06870520","article-title":"Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial","volume":"15","author":"Ito","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10157-020-01963-z","article-title":"Apararenone in Patients with Diabetic Nephropathy: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose\u2013Response Study and Open-Label Extension Study","volume":"25","author":"Wada","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the Management of Arterial Hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Aminuddin, A., Brown, M.J., and Azizan, E.A. (2024). Evaluating the Role of Aldosterone Synthesis on Adrenal Cell Fate. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1423027"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease: The FIDELITY Pooled Analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2015.05.127","article-title":"Safety Profile of Mineralocorticoid Receptor Antagonists: Spironolactone and Eplerenone","volume":"200","author":"Lainscak","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1204598","DOI":"10.1155\/2018\/1204598","article-title":"Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology","volume":"2018","author":"Cannavo","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"i62","DOI":"10.1093\/ndt\/gft402","article-title":"Aldosterone Synthase Inhibitors in Cardiovascular and Renal Diseases","volume":"29","author":"Namsolleck","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"H670","DOI":"10.1152\/ajpheart.00419.2023","article-title":"Aldosterone and Aldosterone Synthase Inhibitors in Cardiorenal Disease","volume":"326","author":"Verma","year":"2024","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1159\/000542621","article-title":"Aldosterone Synthase Inhibitors for Cardiorenal Protection: Ready for Prime Time?","volume":"49","author":"Mazzieri","year":"2024","journal-title":"Kidney Blood Press. Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1210\/clinem\/dgad071","article-title":"Aldosterone Synthase Inhibitors and the Treatment of Essential Hypertension","volume":"108","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"bvaf027","DOI":"10.1210\/jendso\/bvaf027","article-title":"Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations","volume":"9","author":"Fleseriu","year":"2025","journal-title":"J. Endocr. Soc."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Forzano, I., Mone, P., Varzideh, F., Jankauskas, S.S., Kansakar, U., De Luca, A., and Santulli, G. (2022). The Selective Aldosterone Synthase Inhibitor Baxdrostat Significantly Lowers Blood Pressure in Patients with Resistant Hypertension. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1097968"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41440-022-01070-4","article-title":"Results from a Phase 1, Randomized, Double-Blind, Multiple Ascending Dose Study Characterizing the Pharmacokinetics and Demonstrating the Safety and Selectivity of the Aldosterone Synthase Inhibitor Baxdrostat in Healthy Volunteers","volume":"46","author":"Freeman","year":"2023","journal-title":"Hypertens. Res."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Heerspink, H.J.L., Little, D.J., Myte, R., Zaozerska, N., Menzies, R.I., Perl, S., Chertow, G.M., and Dwyer, J.P. (2024). Effect of Baxdrostat on Albuminuria in Treatment-Resistant Hypertension: SA-PO353. J. Am. Soc. Nephrol., 35.","DOI":"10.1681\/ASN.2024fbrh9bc4"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.2023.16029","article-title":"Target-HTN Investigators Aldosterone Synthase Inhibition with Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial","volume":"330","author":"Laffin","year":"2023","journal-title":"JAMA"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2501440","article-title":"Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension","volume":"392","author":"Laffin","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_165","unstructured":"Prakash, Y.S. (2023). Aldosterone: Renal Action and Physiological Effects. Comprehensive Physiology, Wiley."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/cvr\/cvy252","article-title":"Pharmacological Inhibition of the NLRP3 Inflammasome Reduces Blood Pressure, Renal Damage, and Dysfunction in Salt-Sensitive Hypertension","volume":"115","author":"Krishnan","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_167","first-page":"9","article-title":"The nlrp3 inhibitor dapansutrile improves the therapeutic action of lonafarnib on progeroid mice","volume":"23","author":"Collado","year":"2024","journal-title":"Aging Cell"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","article-title":"Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II\u2013III Systolic Heart Failure","volume":"77","author":"Wohlford","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI31008","article-title":"TLR4 Activation Mediates Kidney Ischemia\/Reperfusion Injury","volume":"117","author":"Wu","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Ma, J., Chadban, S.J., Zhao, C.Y., Chen, X., Kwan, T., Panchapakesan, U., Pollock, C.A., and Wu, H. (2014). TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097985"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Wang, X., Chai, Y., Dou, Y., Li, X., Li, F., and Gao, K. (2025). Global Trends and Hotspots in Macrophage Research Related to Hypertension from 2015-2024: Bibliometric Research and Visualization Analysis. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1501432"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A Randomized, Double-Blind, Placebo-Controlled Trial of TAK-242 for the Treatment of Severe Sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.181123","article-title":"T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury","volume":"59","author":"Kasal","year":"2012","journal-title":"Hypertension"},{"key":"ref_174","first-page":"132","article-title":"The Th17\/Treg Imbalance in Patients with Primary Hyperaldosteronism and Resistant Hypertension","volume":"132","author":"Imiela","year":"2021","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"D\u2019Amato, A., Prosperi, S., Severino, P., Myftari, V., Correale, M., Perrone Filardi, P., Badagliacca, R., Fedele, F., Vizza, C.D., and Palazzuoli, A. (2024). MicroRNA and Heart Failure: A Novel Promising Diagnostic and Therapeutic Tool. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247560"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/HYPERTENSIONAHA.124.23418","article-title":"Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism","volume":"81","author":"Herold","year":"2024","journal-title":"Hypertension"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Langlo, K.A.R., Silva, G.J.J., Overrein, T.S., Adams, V., Wisl\u00f8ff, U., Dalen, H., Rolim, N., and Hallan, S.I. (2021). Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.626699"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.HYP.0000259797.48382.b2","article-title":"Nongenomic Actions of Aldosterone on the Renal Tubule","volume":"49","author":"Good","year":"2007","journal-title":"Hypertension"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.120.317424","article-title":"Mineralocorticoid Receptors: Master Regulators of Extracellular Matrix Remodeling","volume":"127","author":"Lother","year":"2020","journal-title":"Circ. Res."},{"key":"ref_180","unstructured":"Rajkumar, V., and Waseem, M. (2025). Hypoaldosteronism. StatPearls, StatPearls Publishing."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1210\/clinem\/dgaa765","article-title":"Molecular Analysis of the CYP11B2 Gene in 62 Patients with Hypoaldosteronism Due to Aldosterone Synthase Deficiency","volume":"106","author":"Merakou","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jha2.801","article-title":"Heparininduced Hyperkalemia, Can LMWH Cause Hyperkalemia? A Systematic Review","volume":"4","author":"Amdetsion","year":"2023","journal-title":"eJHaem"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4239\/wjd.v7.i5.101","article-title":"Hyporeninemic Hypoaldosteronism and Diabetes Mellitus: Pathophysiology Assumptions, Clinical Aspects and Implications for Management","volume":"7","author":"Sousa","year":"2016","journal-title":"World J. Diabetes"},{"key":"ref_185","first-page":"130010","article-title":"Pseudohypoaldosteronism Type 1: Clinical Features and Management in Infancy","volume":"2013","author":"Amin","year":"2013","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Nakata, Y., Nagano, C., Imagawa, Y., Shirai, K., Masuda, Y., Kido, T., Ashina, M., Nozu, K., and Fujioka, K. (2025). Clinical and Biochemical Characteristics of Pseudohypoaldosteronism Type 1 with and Without Genetic Mutations: A Literature Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14134408"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Mabillard, H., and Sayer, J.A. (2019). The Molecular Genetics of Gordon Syndrome. Genes, 10.","DOI":"10.3390\/genes10120986"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Delforge, X., Kongolo, G., Cauliez, A., Braun, K., Haraux, E., and Buisson, P. (2019). Transient Pseudohypoaldosteronism: A Potentially Severe Condition Affecting Infants with Urinary Tract Malformation. J. Pediatr. Urol., 15.","DOI":"10.1016\/j.jpurol.2019.03.002"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/18\/8829\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:43:29Z","timestamp":1760035409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/18\/8829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":188,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26188829"],"URL":"https:\/\/doi.org\/10.3390\/ijms26188829","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}